Eris Lifesciences is trading -0.92% lower at Rs 1,757.95 as compared to its last closing price. Eris Lifesciences has been trading in the price range of 1,797.65 & 1,715.05. Eris Lifesciences has given 29.31% in this year & 1.86% in the last 5 days. Eris Lifesciences has TTM P/E ratio 54.83 as compared to the sector P/E of 25.87.There are 9 analysts who have initiated coverage on Eris Lifesciences. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 93.45 Crores in its last quarter.Listed peers of Eris Lifesciences include Syngene International (-1.93%), J B Chemicals And Pharmaceutical (-1.03%), Eris Lifesciences (-0.92%).The Mutual Fund holding in Eris Lifesciences was at 16.59% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Eris Lifesciences was at 8.43% in 31 Mar 2025. The FII holding has increased from the last quarter.
Updated on Jul 19, 2025, 06:24 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Syngene International | Neutral | 656.40 | -1.93 | 26,448.94 | 54.31 | 5.44 | 0.20 | 8.65 |
J B Chemicals And Pharmaceutical | Bullish | 1,647.00 | -1.03 | 25,801.36 | 39.45 | 7.43 | 0.75 | 0.19 |
Eris Lifesciences | Bullish | 1,757.95 | -0.92 | 23,866.14 | 66.44 | 8.2 | 0.43 | 62.42 |
Alembic Pharmaceuticals | Bullish | 1,029.80 | -0.42 | 20,205.93 | 34.73 | 3.81 | 1.09 | 0.90 |
Jubilant Pharmova | Bullish | 1,234.90 | 2.87 | 19,645.08 | 35.82 | 3.04 | 0.42 | 38.19 |
Meeting Date | Purpose |
---|---|
2025-05-19 | Audited Results |
2025-02-07 | Interim Dividend |
2025-02-04 | Quarterly Results |
2024-10-25 | Quarterly Results |
2024-08-02 | Quarterly Results |
Eris Lifesciences is trading at 1757.95 as on Fri Jul 18 2025 09:59:00. This is -0.92% lower as compared to its previous closing price of 1774.30.
The market capitalization of Eris Lifesciences is 23866.14 Cr as on Fri Jul 18 2025 09:59:00.
The 52 wk high for Eris Lifesciences is 1909.55 whereas the 52 wk low is 988.95
Eris Lifesciences can be analyzed on the following key metrics -
Eris Lifesciences reported a net profit of 351.84 Cr in 2025.
The Mutual Fund Shareholding was 16.59% at the end of 31 Mar 2025.